Filed: 2/14/2023ACC: 0001104659-23-020417
📋 What this filing means
5AM VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $372.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$372.12M
Total AUM (reported)
54.20M
Total Shares
Allocation by class
COM$352.36M94.7%
CLASS A COM$19.76M5.3%
Portfolio Concentration
Top 3$162.59M43.7%
4–10$127.87M34.4%
11–25$81.66M21.9%
Top 3 weight
43.7%
Top 10 weight
78.1%
Voting Authority Distribution
Total shares with voting rights: 54.20M
Sole
Full voting authority
54.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
CINCOR PHARMA INC
SOLEShares4.94M
TypeSH
Market value$60.68M
16.31%
Sole
4.94M
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares4.41M
TypeSH
Market value$59.60M
16.02%
Sole
4.41M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares6.36M
TypeSH
Market value$42.31M
11.37%
Sole
6.36M
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares3.73M
TypeSH
Market value$24.51M
6.59%
Sole
3.73M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.20M
TypeSH
Market value$21.74M
5.84%
Sole
1.20M
Shared
0.00
None
0.00
PEAR THERAPEUTICS INC
SOLEShares16.74M
TypeSH
Market value$19.76M
5.31%
Sole
16.74M
Shared
0.00
None
0.00
SCPHARMACEUTICALS INC
SOLEShares2.73M
TypeSH
Market value$19.61M
5.27%
Sole
2.73M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares862.29K
TypeSH
Market value$15.78M
4.24%
Sole
862.29K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares665.55K
TypeSH
Market value$14.77M
3.97%
Sole
665.55K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares588.44K
TypeSH
Market value$11.70M
3.15%
Sole
588.44K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares357.73K
TypeSH
Market value$11.09M
2.98%
Sole
357.73K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares320K
TypeSH
Market value$10.95M
2.94%
Sole
320K
Shared
0.00
None
0.00
IMPEL NEUROPHARMA INC
SOLEShares2.88M
TypeSH
Market value$10.82M
2.91%
Sole
2.88M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares790.44K
TypeSH
Market value$9.14M
2.46%
Sole
790.44K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$8.76M
2.35%
Sole
300K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares384.63K
TypeSH
Market value$8.23M
2.21%
Sole
384.63K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares587.60K
TypeSH
Market value$6.61M
1.78%
Sole
587.60K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares446.27K
TypeSH
Market value$5.88M
1.58%
Sole
446.27K
Shared
0.00
None
0.00
HOMOLOGY MEDICINES INC
SOLEShares4.54M
TypeSH
Market value$5.72M
1.54%
Sole
4.54M
Shared
0.00
None
0.00
FIBROGEN INC
SOLEShares225.58K
TypeSH
Market value$3.61M
0.97%
Sole
225.58K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares1.13M
TypeSH
Market value$858.0K
0.23%
Sole
1.13M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CINCOR PHARMA INCSOLE | COM | 4.94M | SH | $60.68M 16.31% | 4.94M | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COM | 4.41M | SH | $59.60M 16.02% | 4.41M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 6.36M | SH | $42.31M 11.37% | 6.36M | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 3.73M | SH | $24.51M 6.59% | 3.73M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.20M | SH | $21.74M 5.84% | 1.20M | 0.00 | 0.00 |
PEAR THERAPEUTICS INCSOLE | CLASS A COM | 16.74M | SH | $19.76M 5.31% | 16.74M | 0.00 | 0.00 |
SCPHARMACEUTICALS INCSOLE | COM | 2.73M | SH | $19.61M 5.27% | 2.73M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 862.29K | SH | $15.78M 4.24% | 862.29K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 665.55K | SH | $14.77M 3.97% | 665.55K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 588.44K | SH | $11.70M 3.15% | 588.44K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 357.73K | SH | $11.09M 2.98% | 357.73K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 320K | SH | $10.95M 2.94% | 320K | 0.00 | 0.00 |
IMPEL NEUROPHARMA INCSOLE | COM | 2.88M | SH | $10.82M 2.91% | 2.88M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 790.44K | SH | $9.14M 2.46% | 790.44K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 300K | SH | $8.76M 2.35% | 300K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 384.63K | SH | $8.23M 2.21% | 384.63K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 587.60K | SH | $6.61M 1.78% | 587.60K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 446.27K | SH | $5.88M 1.58% | 446.27K | 0.00 | 0.00 |
HOMOLOGY MEDICINES INCSOLE | COM | 4.54M | SH | $5.72M 1.54% | 4.54M | 0.00 | 0.00 |
FIBROGEN INCSOLE | COM | 225.58K | SH | $3.61M 0.97% | 225.58K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM | 1.13M | SH | $858.0K 0.23% | 1.13M | 0.00 | 0.00 |